» Articles » PMID: 23559092

Small Interfering RNA Targeting Rac1 Sensitizes Colon Cancer to Dihydroartemisinin-induced Cell Cycle Arrest and Inhibited Cell Migration by Suppressing NFκB Activity

Overview
Publisher Springer
Specialty Biochemistry
Date 2013 Apr 6
PMID 23559092
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Dihydroartemisinin (DHA) has recently shown antitumor activity in various cancer cells. The small GTPase Rac1 regulates many cellular processes, including cytoskeletal reorganization, cell migration, proliferation, and survival. In addition, Rac1 plays a major role in activating NFκB-mediated transcription. Both Rac1 and NFκB regulate many properties of the malignant phenotype, including anchorage-independent proliferation and survival, metastasis, and angiogenesis. In this study, for the first time, we demonstrated that Rac1 knockdown can enhance DHA-induced growth inhibition, cell cycle arrest, apoptosis, and migration in both HCT116 and RKO cell lines in vitro. The mechanism is due partially to DHA, and Rac1 siRNA deactivates NFκB activity, so as to decrease tremendously the expression of its target gene products, such as PCNA, cyclin D1, and CDK4; and increase the expression of p21, cleaved-caspase-3, and cleaved-PARP. In our in vivo studies, DHA also manifested remarkably enhanced antitumor effect when combined with Rac1 siRNA. We concluded that inhibition of NFκB activation is one of the mechanisms that Rac1 siRNA dramatically promotes DHAs antitumor effect on human colon cancer.

Citing Articles

Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy.

Xie J, Wang S Technol Cancer Res Treat. 2022; 21:15330338221103318.

PMID: 35899305 PMC: 9340422. DOI: 10.1177/15330338221103318.


Dihydroartemisinin: A Potential Natural Anticancer Drug.

Dai X, Zhang X, Chen W, Chen Y, Zhang Q, Mo S Int J Biol Sci. 2021; 17(2):603-622.

PMID: 33613116 PMC: 7893584. DOI: 10.7150/ijbs.50364.


Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer.

Cooke M, Baker M, Kazanietz M Front Cell Dev Biol. 2020; 8:118.

PMID: 32158759 PMC: 7051914. DOI: 10.3389/fcell.2020.00118.


Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Zhang Y, Xu G, Zhang S, Wang D, Saravana Prabha P, Zuo Z Nat Prod Bioprospect. 2018; 8(4):303-319.

PMID: 29633188 PMC: 6102173. DOI: 10.1007/s13659-018-0162-1.


Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1/c-Myc signaling in T-cell lymphoma cells.

Huo L, Wei W, Wu S, Zhao X, Zhao C, Zhao H Exp Ther Med. 2018; 15(3):3059-3065.

PMID: 29599840 PMC: 5867475. DOI: 10.3892/etm.2018.5784.


References
1.
Bork P, Schmitz M, Kuhnt M, Escher C, Heinrich M . Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett. 1997; 402(1):85-90. DOI: 10.1016/s0014-5793(96)01502-5. View

2.
Espey D, Wu X, Swan J, Wiggins C, Jim M, Ward E . Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007; 110(10):2119-52. DOI: 10.1002/cncr.23044. View

3.
Disbrow G, Baege A, Kierpiec K, Yuan H, Centeno J, Thibodeaux C . Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res. 2005; 65(23):10854-61. DOI: 10.1158/0008-5472.CAN-05-1216. View

4.
Saif M . Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer. 2006; 6(1):46-51. DOI: 10.3816/CCC.2006.n.020. View

5.
Sulciner D, Irani K, Yu Z, Ferrans V, Goldschmidt-Clermont P, Finkel T . rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol. 1996; 16(12):7115-21. PMC: 231715. DOI: 10.1128/MCB.16.12.7115. View